305 related articles for article (PubMed ID: 11473067)
21. A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects.
Kaufman FR; Gibson LC; Halvorson M; Carpenter S; Fisher LK; Pitukcheewanont P
Diabetes Care; 2001 Dec; 24(12):2030-4. PubMed ID: 11723078
[TBL] [Abstract][Full Text] [Related]
22. Algorithmic evaluation of metabolic control and risk of severe hypoglycemia in type 1 and type 2 diabetes using self-monitoring blood glucose data.
Kovatchev BP; Cox DJ; Kumar A; Gonder-Frederick L; Clarke WL
Diabetes Technol Ther; 2003; 5(5):817-28. PubMed ID: 14633347
[TBL] [Abstract][Full Text] [Related]
23. Reducing rates of severe hypoglycemia in a population-based cohort of children and adolescents with type 1 diabetes over the decade 2000-2009.
O'Connell SM; Cooper MN; Bulsara MK; Davis EA; Jones TW
Diabetes Care; 2011 Nov; 34(11):2379-80. PubMed ID: 21926291
[TBL] [Abstract][Full Text] [Related]
24. Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).
Murata GH; Shah JH; Hoffman RM; Wendel CS; Adam KD; Solvas PA; Bokhari SU; Duckworth WC;
Diabetes Care; 2003 Jun; 26(6):1759-63. PubMed ID: 12766106
[TBL] [Abstract][Full Text] [Related]
25. A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes.
Fox LA; Buckloh LM; Smith SD; Wysocki T; Mauras N
Diabetes Care; 2005 Jun; 28(6):1277-81. PubMed ID: 15920039
[TBL] [Abstract][Full Text] [Related]
26. Glycemic control in youth with diabetes: the SEARCH for diabetes in Youth Study.
Petitti DB; Klingensmith GJ; Bell RA; Andrews JS; Dabelea D; Imperatore G; Marcovina S; Pihoker C; Standiford D; Waitzfelder B; Mayer-Davis E;
J Pediatr; 2009 Nov; 155(5):668-72.e1-3. PubMed ID: 19643434
[TBL] [Abstract][Full Text] [Related]
27. Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial.
Hermanides J; Nørgaard K; Bruttomesso D; Mathieu C; Frid A; Dayan CM; Diem P; Fermon C; Wentholt IM; Hoekstra JB; DeVries JH
Diabet Med; 2011 Oct; 28(10):1158-67. PubMed ID: 21294770
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with glycemic control. A cross-sectional nationwide study in 2,579 French children with type 1 diabetes. The French Pediatric Diabetes Group.
Rosilio M; Cotton JB; Wieliczko MC; Gendrault B; Carel JC; Couvaras O; Ser N; Gillet P; Soskin S; Garandeau P; Stuckens C; Le Luyer B; Jos J; Bony-Trifunovic H; Bertrand AM; Leturcq F; Lafuma A; French Pediatric Diabetes Group ; Bougnères PF
Diabetes Care; 1998 Jul; 21(7):1146-53. PubMed ID: 9653610
[TBL] [Abstract][Full Text] [Related]
29. Improved glycemic control with use of continuous subcutaneous insulin infusion compared with multiple insulin injection therapy.
Bell DS; Ovalle F
Endocr Pract; 2000; 6(5):357-60. PubMed ID: 11141585
[TBL] [Abstract][Full Text] [Related]
30. Glycemic control with insulin glargine plus insulin glulisine versus premixed insulin analogues in real-world practices: a cost-effectiveness study with a randomized pragmatic trial design.
Levin PA; Zhang Q; Mersey JH; Lee FY; Bromberger LA; Bhushan M; Bhushan R
Clin Ther; 2011 Jul; 33(7):841-50. PubMed ID: 21719107
[TBL] [Abstract][Full Text] [Related]
31. Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries.
Danne T; Battelino T; Jarosz-Chobot P; Kordonouri O; Pánkowska E; Ludvigsson J; Schober E; Kaprio E; Saukkonen T; Nicolino M; Tubiana-Rufi N; Klinkert C; Haberland H; Vazeou A; Madacsy L; Zangen D; Cherubini V; Rabbone I; Toni S; de Beaufort C; Bakker-van Waarde W; van den Berg N; Volkov I; Barrio R; Hanas R; Zumsteg U; Kuhlmann B; Aebi C; Schumacher U; Gschwend S; Hindmarsh P; Torres M; Shehadeh N; Phillip M;
Diabetologia; 2008 Sep; 51(9):1594-601. PubMed ID: 18592209
[TBL] [Abstract][Full Text] [Related]
32. Predictors of glycaemic control and hypoglycaemia in children and adolescents with type 1 diabetes from NSW and the ACT.
Craig ME; Handelsman P; Donaghue KC; Chan A; Blades B; Laina R; Bradford D; Middlehurst A; Ambler G; Verge CF; Crock P; Moore P; Silink M;
Med J Aust; 2002 Sep; 177(5):235-8. PubMed ID: 12197816
[TBL] [Abstract][Full Text] [Related]
33. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes.
Hamann A; Matthaei S; Rosak C; Silvestre L;
Diabetes Care; 2003 Jun; 26(6):1738-44. PubMed ID: 12766103
[TBL] [Abstract][Full Text] [Related]
34. Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.
Roach P; Bai S; Charbonnel B; Consoli A; Taboga C; Tiengo A; Bolli G;
Clin Ther; 2004 Apr; 26(4):502-10. PubMed ID: 15189747
[TBL] [Abstract][Full Text] [Related]
35. Clinical effectiveness of biphasic insulin aspart 30:70 versus biphasic human insulin 30 in UK general clinical practice: a retrospective database study.
Morgan CL; Evans M; Toft AD; Jenkins-Jones S; Poole CD; Currie CJ
Clin Ther; 2011 Jan; 33(1):27-35. PubMed ID: 21397771
[TBL] [Abstract][Full Text] [Related]
36. Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion.
Weintrob N; Schechter A; Benzaquen H; Shalitin S; Lilos P; Galatzer A; Phillip M
Arch Pediatr Adolesc Med; 2004 Jul; 158(7):677-84. PubMed ID: 15237068
[TBL] [Abstract][Full Text] [Related]
37. Predictors of acute complications in children with type 1 diabetes.
Rewers A; Chase HP; Mackenzie T; Walravens P; Roback M; Rewers M; Hamman RF; Klingensmith G
JAMA; 2002 May; 287(19):2511-8. PubMed ID: 12020331
[TBL] [Abstract][Full Text] [Related]
38. Long-term efficacy of insulin glargine after switching from NPH insulin as intensive replacement of basal insulin in Japanese diabetes mellitus. Comparison of efficacy between type 1 and type 2 diabetes (JUN-LAN Study 1.2).
Kanazawa Y; Igarashi Y; Komiya K; Sakurai Y; Shimizu T; Fujitani Y; Tanaka Y; Watada H; Kawamori R; Hirose T
Endocr J; 2007 Dec; 54(6):975-83. PubMed ID: 18000343
[TBL] [Abstract][Full Text] [Related]
39. Insulin injection regimens and metabolic control in an international survey of adolescents with type 1 diabetes over 3 years: results from the Hvidore study group.
Holl RW; Swift PG; Mortensen HB; Lynggaard H; Hougaard P; Aanstoot HJ; Chiarelli F; Daneman D; Danne T; Dorchy H; Garandeau P; Greene S; Hoey HM; Kaprio EA; Kocova M; Martul P; Matsuura N; Robertson KJ; Schoenle EJ; Sovik O; Tsou RM; Vanelli M; Aman J
Eur J Pediatr; 2003 Jan; 162(1):22-9. PubMed ID: 12486503
[TBL] [Abstract][Full Text] [Related]
40. Changes in treatment adherence and glycemic control during the transition to adolescence in type 1 diabetes.
Rausch JR; Hood KK; Delamater A; Shroff Pendley J; Rohan JM; Reeves G; Dolan L; Drotar D
Diabetes Care; 2012 Jun; 35(6):1219-24. PubMed ID: 22474040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
